0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP NI658976 2023-03-01 2024-02-29 NI658976 2024-02-29 NI658976 2023-02-28 NI658976 2022-03-01 2023-02-28 NI658976 2023-02-28 NI658976 2022-02-28 NI658976 bus:Director2 2023-03-01 2024-02-29 NI658976 core:WithinOneYear 2024-02-29 NI658976 core:WithinOneYear 2023-02-28 NI658976 core:AfterOneYear 2024-02-29 NI658976 core:AfterOneYear 2023-02-28 NI658976 bus:Micro-entities 2023-03-01 2024-02-29 NI658976 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 NI658976 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 NI658976 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 NI658976 bus:FullAccounts 2023-03-01 2024-02-29
COMPANY REGISTRATION NUMBER: NI658976
42 Genetics Ltd
Filleted Unaudited Financial Statements
29 February 2024
42 Genetics Ltd
Statement of Financial Position
29 February 2024
2024
2023
£
£
Fixed assets
1,150,693
1,039,377
------------
------------
Current assets
44,501
186,759
Creditors: amounts falling due within one year
356,582
50,302
------------
------------
Net current (liabilities)/assets
( 312,081)
136,457
---------
------------
Total assets less current liabilities
838,612
1,175,834
Creditors: amounts falling due after more than one year
24,897
32,500
Accruals and deferred income
1,650
173,185
---------
------------
812,065
970,149
---------
------------
Capital and reserves
812,065
970,149
---------
---------
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 22 November 2024 , and are signed on behalf of the board by:
Mr R Irwin
Director
Company registration number: NI658976
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 42 Genetics Limited, Innovation Centre, Queens Road, Belfast, BT3 9DT, Northern Ireland.